PLIANT THERAPEUTICS, INC. Accounts Payable
PLIANT THERAPEUTICS, INC. (PLRX) had Accounts Payable of $1.53 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-11
- 2026-06-30: Accounts Payable, Current $1.53M.
- 2026-03-31: Accounts Payable, Current $362.00K.
- 2025-12-31: Accounts Payable, Current $480.00K.
- 2025-09-30: Accounts Payable, Current $485.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.53M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $362.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $480.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $485.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.38M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $5.62M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $5.96M 10-K · filed 2026-03-11 |
| 2024-09-30 | $6.89M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.25M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $7.33M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $4.53M 10-K · filed 2025-03-03 |
| 2023-09-30 | $3.36M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.31M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.42M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.58M 10-K · filed 2024-02-27 |
| 2022-09-30 | $3.21M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.12M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $4.68M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $2.97M 10-K · filed 2023-03-09 |
| 2021-09-30 | $2.60M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.76M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $2.89M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $2.02M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.14M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.48M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $1.25M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |